Publications in collaboration with researchers from Centro de Investigación Biomédica en Red de Cáncer (11)

2025

  1. A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 122, Núm. 49

  2. CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia

    Journal of Hematology and Oncology, Vol. 18, Núm. 1

  3. Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801

    Clinical and Translational Oncology

2024

  1. Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression

    EMBO molecular medicine, Vol. 16, Núm. 1, pp. 64-92

  2. Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells

    HemaSphere, Vol. 8, Núm. 2

2023

  1. TIM3, a human acute myeloid leukemia stem cell marker, does not enrich for leukemia-initiating stem cells in B-cell acute lymphoblastic leukemia

    Haematologica

  2. The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP)

    Frontiers in Pediatrics, Vol. 11

2022

  1. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia

    Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919

  2. The value of sentinel lymph-node biopsy after neoadjuvant therapy: an overview

    Clinical and Translational Oncology, Vol. 24, Núm. 9, pp. 1744-1754

2020

  1. Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

    Frontiers in Pediatrics, Vol. 8

2019

  1. Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis

    Haematologica, Vol. 104, Núm. 2, pp. e54-e58